You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 10, September 9, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Ophthalmology
 •Ophthalmological Disorders
 •Cataracts/ Lens
 •Ophthalmological Procedures
 •Ophthalmological Procedures, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tamsulosin and Ophthalmic Adverse Events After Cataract Surgery

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Bell and colleagues1 described the association between tamsulosin and adverse events following cataract surgery. The authors theorized that tamsulosin may demonstrate greater receptor affinity and selectivity compared with other antagonists studied, thereby resulting in the observed selective toxicity. However, a hypothesis that tamsulosin is bound to receptors in a manner resulting in protracted selective and specific ocular toxicity is problematic.

Descriptions of receptor affinity developed as a result of formal receptor-ligand assays should not be interpreted as indicating intrinsic (agonist or antagonistic) properties of drug action. Rather than receptor affinity alone, it is the pharmacodynamic consequence of drug exposure described in terms of dose-response relationships that more accurately predicts drug effect.2 The {alpha}1 antagonists examined in the study by Bell et al demonstrate competitive antagonism of {alpha}1 receptor activity, with relative similarity in the agonist-concentration effect (E/[A]) curve shift with increasing agonist concentration.3 Although relative . . . [Full Text of this Article]

Bruce I. Gaynes, OD, PharmD
bgaynes@lumc.edu
Department of Ophthalmology
Loyola University Chicago
Maywood, Illinois



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery
Chaim M. Bell, Wendy V. Hatch, Hadas D. Fischer, Geta Cernat, J. Michael Paterson, Andrea Gruneir, Sudeep S. Gill, Susan E. Bronskill, Geoffrey M. Anderson, and Paula A. Rochon
JAMA. 2009;301(19):1991-1996.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Tamsulosin and Ophthalmic Adverse Events After Cataract Surgery
Sergio Ponce-de-Leon
JAMA. 2009;302(10):1054.
EXTRACT | FULL TEXT  

Tamsulosin and Ophthalmic Adverse Events After Cataract Surgery—Reply
Chaim Bell, Andrea Gruneir, and Paula Rochon
JAMA. 2009;302(10):1055.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.